Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Inhibits the Progression of Group B Streptococcal Arthritis

Glucuronoxylomannan (GXM), the principal constituent of the Cryptococcus neoformans capsule, modulates the inflammatory response of human monocytes in vitro. Here we examine the efficacy of GXM as a novel anti-inflammatory compound for use against experimental septic arthritis. Arthritis was induced...

Descrición completa

Detalles Bibliográficos

Publicado en:	Infect Immun
Principais autores:	Tissi, Luciana, Puliti, Manuela, Bistoni, Francesco, Mosci, Paolo, Kozel, Thomas R., Vecchiarelli, Anna
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 2004
Assuntos:	Molecular Pathogenesis
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC523051/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15501766/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.72.11.6367-6372.2004
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!